Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2.
Robays J, Stordeur S, Hulstaert F, Baurain J-F, Brochez L, Caplanusi T, Claes K, Legius E, Rottey S, Schrijvers D, t'Kint de Roodenbeke D, Ullman U, Van Maerken T, Poppe B
Record ID 32015000835
English
Authors' objectives:
This guideline treats the Birt-Hogg-Dubé syndrome, the familial atypical multiple mole melanoma syndrome and neurofibromatosis 1&2. These syndromes only have in common that dermatological manifestations are
involved, but implications, risks and issues around testing and follow-up are very diverse. A specific background will be given for each syndrome separately.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://kce.fgov.be/sites/default/files/page_documents/KCE_243_oncogenetic_testing_Neurofibromatosis_Report.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Belgium
MeSH Terms
- Biomarkers, Tumor
- Birt-Hogg-Dube Syndrome
- Neoplasms, Multiple Primary
- Melanoma
- Skin Neoplasms
- Dysplastic Nevus Syndrome
- Genes, Neurofibromatosis 1
- Neurofibromatosis 1
- Neurofibromatosis 2
- Genes, Neurofibromatosis 2
Contact
Organisation Name:
Belgian Health Care Knowledge Centre
Contact Address:
Administrative Centre Botanique, Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, B-1000 Brussels, Belgium tel: +32 2 287 33 88 fax: +32 2 287 33 85
Contact Name:
info@kce.fgov.be
Contact Email:
info@kce.fgov.be
Copyright:
Belgian Health Care Knowledge Centre (KCE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.